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Evidence for auto-inhibition by the N terminus of hADAR2
and activation by dsRNA binding
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ABSTRACT
Adenosine deaminases that act on RNA (ADARs) catalyze adenosine to inosine conversion in RNA that is largely double
stranded. Human ADAR2 (hADAR2) contains two double-stranded RNA binding motifs (dsRBMs), separated by a 90-amino acid
linker, and these are followed by the C-terminal catalytic domain. We assayed enzymatic activity of N-terminal deletion
constructs of hADAR2 to determine the role of the dsRBMs and the intervening linker peptide. We found that a truncated
protein consisting of one dsRBM and the deaminase domain was capable of deaminating a short 15-bp substrate. In contrast,
full-length hADAR2 was inactive on this short substrate. In addition, we observed that the N terminus, which was deleted from
the truncated protein, inhibits editing activity when added in trans. We propose that the N-terminal domain of hADAR2 contains
sequences that cause auto-inhibition of the enzyme. Our results suggest activation requires binding to an RNA substrate long
enough to accommodate interactions with both dsRBMs.
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INTRODUCTION
RNA editing by adenosine deamination is catalyzed by
members of an enzyme family known as adenosine deami-
nases that act on RNA (ADARs; Bass 2002). The RNA sub-
strates for ADARs are largely double stranded, and the
product of the reaction is RNA that contains inosine. Cel-
lular enzymes recognize inosine as guanosine, and thus,
ADARs change the primary sequence information of RNA.
In addition, ADARs are capable of altering RNA structure
by changing AU base pairs to IU mismatches, or AC mis-
matches to IC base pairs. In vivo, human ADARs (hADARs)
deaminate adenosines in coding regions of glutamate and
serotonin receptor pre-mRNAs, in the hepatitis delta virus
antigenome, and in noncoding regions of mRNAs such as
introns and UTRs (Sommer et al. 1991; Lomeli et al. 1994;
Polson et al. 1996; Burns et al. 1997; Morse et al. 2002).
Purified enzyme preparations deaminate the same aden-
osines as observed in vivo, indicating that specificity is in-
trinsic to the enzyme and does not require other factors
(Maas et al. 1996; Polson et al. 1996).
All ADARs have a conserved C-terminal deaminase do-
main and contain from one to three double-stranded RNA
binding motifs (dsRBMs) that comprise the N-terminal
RNA binding domain. Different ADARs exhibit varying dis-
tances between the dsRBMs. For example, the distance be-
tween the two dsRBMs in hADAR2 is ∼90 residues, more
than twice as long as the analogous sequence in hADAR1.
The N termini of several ADARs have been deleted, and the
resulting truncated proteins show varying levels of activity.
For example, when all three of the dsRBMs of rat ADAR1
are deleted from the N terminus, the resulting protein re-
tains deaminase activity in vivo (Herbert and Rich 2001). In
contrast, when the first two dsRBMs of hADAR1 are de-
leted, leaving dsRBM3 and the catalytic domain, the result-
ing protein is not active in vitro (Liu et al. 2000). In addi-
tion, when the extreme N terminus of Drosophila melano-
gaster ADAR (dADAR) is deleted, leaving both of its two
dsRBMs intact, the protein is inactive in vitro, but retains
the ability to bind dsRNA (Gallo et al. 2003).
We conducted a study to characterize the contribution of
the dsRBMs, and the linker sequence between them, to
deamination by hADAR2 in vitro. We constructed several
N-terminal deletion mutants of hADAR2 and determined
the ability of each to deaminate RNA. From our results, we
suggest hADAR2 is subject to auto-inhibition by sequences
in the N-terminal domain. Activation requires binding to
dsRNA and does not occur with dsRNA of very short
length, raising the possibility that auto-inhibition functions
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enous RNA. In our model, activation involves binding of
dsRBM1 to an extended RNA duplex, which then allows for
binding of dsRBM2 and deamination of the substrate by the
catalytic domain.
RESULTS
Limited proteolysis of hADAR2
We subjected purified hADAR2 to limited proteolysis using
subtilisin and trypsin to find stable domains that retained
deaminase activity. Subtilisin nonspecifically cleaves peptide
bonds in solvent-accessible regions, and trypsin is specific
for accessible peptide bonds that are C terminal to basic
amino acids. A 1-h time course showed that both subtilisin
and trypsin rapidly degrade the full-length ADAR2 into
smaller fragments within 1 min (Fig. 1A). However, some of
the smaller polypeptides were exceptionally stable and re-
mained intact for the full hour (Fig. 1A). Subtilisin diges-
tion produced numerous fragments, two of which were
prominent (∼61 kDa and ∼55 kDa), whereas trypsin gave
one prominent fragment (∼61 kDa). Chymotrypsin showed
a proteolysis profile similar to that of subtilisin (data not
shown). The N termini of several of the larger fragments
were sequenced to determine the sites of proteolysis, and
the results are presented in schematic form in Figure 1B. All
protease sites were clustered in two regions outside of the
characterized domains of hADAR2, and the majority of the
sites were in the linker between the two dsRBMs.
On the basis of the proteolysis results, we cloned and
overexpressed three truncations of hADAR2 (Fig. 2A). The
constructs are named from the motifs that remain after
deletion of the N terminus. Truncation R1LR2D, in which
the N terminus up to the first dsRBM is deleted, retains
amino acids 77–701 including dsRBM1, the linker between
the dsRBMs, dsRBM2, and the deaminase domain; this
truncation is similar to a recently described truncation of
ADAR from D. melanogaster (Gallo et al. 2003). In the LR2D
truncation, the N terminus, including the first dsRBM and
the first 16 amino acids of the 92 residue linker between the
two dsRBMs, is deleted, leaving residues 160–701, which
include most of the linker, dsRBM2, and the deaminase
domain. The R2D truncation encompasses residues 216–701
and leaves only dsRBM2 and the deaminase domain intact.
Expression and deaminase activity of N-terminal
deletion constructs
The three truncations of hADAR2, each containing a 6×-
histidine tag at the C terminus, were expressed in the yeast
Saccharomyces cerevisiae. To test for expression efficiency,
we analyzed clarified cell extracts of cultures expressing the
different truncations by Western blot using an anti-His an-
tibody (Fig. 3A). Because we often observe variation in pro-
tein expression from different clones, we analyzed extracts
from three different clones for each truncation. Each of the
three clones for each truncation were expressed at strong lev-
els, with the expected sizes of ∼70, 61, and 55 kDa (Fig. 3A).
A natural substrate of hADAR2 is the R/G editing site in
the mRNA encoding the B subunit of the glutamate recep-
tor (Lomeli et al. 1994). This adenosine is efficiently deami-
nated by hADAR2 in vitro when in the
context of a small RNA hairpin that
mimics the structure of the pre-mRNA
(Fig. 2C; Öhman et al. 2000). Using the
same extracts (Fig. 3A), we assayed
whether the truncated versions of
hADAR2 were capable of deaminating
this RNA at the R/G site. The R/G hair-
pin was incubated with either purified
hADAR2 or extracts containing one of
the three truncations, and editing was
monitored with a limited primer exten-
sion assay (Öhman et al. 2000). As ex-
pected, the purified hADAR2 efficiently
deaminated the R/G site adenosine,
whereas extract from yeast harboring an
empty expression vector did not (Fig.
3B, negative control). The R1LR2D and
R2D truncations also deaminated the
R/G site adenosine (Fig. 3B). Curiously,
the LR2D truncation, which retains
most of the linker sequence between the
two dsRBMs as well as the second
FIGURE 1. Limited proteolysis of hADAR2. (A) hADAR2 was treated with either subtilisin or
trypsin for the indicated times. The products were run on denaturing polyacrylamide gels and
visualized by staining with Coomassie brilliant blue. Peptides for which the N terminus was
sequenced are labeled with an asterisk. (B) A schematic diagram of hADAR2 showing the
approximate sites of proteolysis as determined by N-terminal sequencing for trypsin (blue
arrows), subtilisin (green arrows), and chymotrypsin (pink arrows; primary data not shown for
chymotrypsin). His 6 denotes a C-terminal tag of six histidine residues.
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activity when activity was assayed in a cell extract (Fig. 3B)
but was active when purified.
Purification of the smallest ADAR truncation
Because the R2D truncation, which contains only dsRBM2
and the catalytic domain, retained deaminase activity, we
decided to characterize its activity in detail. To this end, we
engineered a 10×-histidine tag at the N terminus that was
immediately followed by the tobacco etch virus (TEV) pro-
tease recognition domain, to facilitate removal of nonnative
sequences. The R2D truncation eluted as a monomer from
a gel filtration column at the expected size of 54 kDa (Fig.
4B) and had a high degree of purity (>95%) as assessed by
Coomassie staining of an SDS-polyacrylamide gel (Fig. 4B).
Comparison of editing efficiency of hADAR2 and the
R2D truncation
We directly compared the activities of truncation R2D and
hADAR2 in vitro, using RNAs of several different lengths.
We found both proteins deaminated a long, uniformly la-
beled dsRNA with approximately equal efficiency over the
course of 1 h (Fig. 5A, left panels). To monitor deamination
of a specific adenosine, we prepared intermolecular du-
plexes corresponding to sequences surrounding the R/G
editing site by hybridizing complementary strands of 27
(R/G 27) or 15 (R/G 15) nucleotides long. These molecules
contained one
32P labeled adenosine at the R/G site (Fig.
2C, red). Both proteins deaminated R/G 27 at the R/G
editing site efficiently, with the reaction using the full-
length protein being slightly faster than that of the R2D
truncation (Fig. 5A, center panels). Rather unexpectedly, we
observed that the R2D truncation deaminated R/G 15 far
more efficiently than full-length hADAR2 (Fig. 5A, right
panels).
To quantify these observations, we performed a kinetic
analysis under single-turnover conditions (100 nM enzyme,
5 nM RNA). R/G 27 or R/G 15 RNA, specifically labeled at
the editing site, was incubated with hADAR2 or the R2D
truncation, and product formation was followed using the
TLC assay. The rate of deamination of R/G 27 by hADAR2
was 1.1 min
−1 and only slightly faster than the rate of 0.3
min
−1 for the R2D truncation (Fig. 5B; Table 1). However,
a striking difference in the reaction rates of the two proteins
was observed when using the smaller R/G 15 substrate. The
rate of deamination of this RNA by hADAR2 was very slow,
with a value of 0.00073 min
−1, and the rate with the R2D
truncation was 0.016 min
−1, ∼20-fold faster than the full-
length enzyme (Fig. 5B; Table 1).
Reconstitution of the hADAR2 reaction in trans
Because R2D, but not the full-length hADAR2, edited the
R/G 15 substrate, we wondered whether the full-length pro-
FIGURE 3. Expression and deamination activity of the ADAR trun-
cations. (A) A Western blot using an anti-His antibody to detect the
three tagged truncations of hADAR2 (in triplicate) expressed in S.
cerevisiae. (M) Molecular weight markers. (B) The deaminase activity
of various amounts of extract protein on 2.5-nM R/G hairpin substrate
(see Fig. 2C) was determined with a limited primer extension assay
(Öhman et al. 2000).
FIGURE 2. Protein constructs and RNA substrates. (A) Schematic
representation of hADAR2 constructs with rectangles showing
dsRBMs (striped) and the catalytic domain (solid). (B) Sequence of
the N-terminal RNA binding domain of hADAR2. Sequences corre-
sponding to the two dsRBMs and catalytic domain are capitalized,
amino acids N terminal to the protease cleavage sites are in red, and
the N termini of the truncations that were cloned are denoted by
arrows. The R1 construct begins at the initiator methionine and ends
at the glutamine labeled by the asterisk four residues from the start of
R2D. (C) R/G editing site constructs showing the edited adenosine in
red. (R/G hairpin) Intramolecular stem–loop of 71 nucleotides; (R/G
27 and R/G 15) intermolecular duplexes formed from complementary
strands of 27 and 15 nucleotides, respectively; (R/G terminal hairpin)
a 41-nucleotide-long intramolecular stem–loop representing the ter-
minal stem and loop of the R/G hairpin that does not include the
sequence of R/G 15.
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truncated protein. To explore this possibility, we investi-
gated the effect of adding the N terminus of hADAR2 (con-
struct R1; see Fig. 2) in trans to the R2D editing reaction.
Indeed, we found that R1 inhibited editing of R/G 15 by the
R2D truncation (Fig. 6A, left panel, black bars). In contrast,
but consistent with the observation that both proteins ed-
ited R/G 27, the reaction of R2D with R/G 27 was only
inhibited when the R1 was added at very high concentra-
tions (Fig. 6A, right panel, black bars). Thus, we were able
to mimic the activity of the full-length hADAR2 on both
R/G 15 and R/G 27, in trans, by mixing the R1 and R2D
proteins.
We considered the possibility that R1, which contains
dsRBM1, inhibited the reaction of R2D with R/G 15 simply
by competing for binding to the substrate. To test this idea,
we prepared an N-terminal fragment (R1-K127A) that con-
tained a point mutation in dsRBM1. The analogous muta-
tion in a dsRBM of hADAR1 (Liu and Samuel 1996), as well
as a dsRBM of protein kinase activated by RNA (PKR; Mil-
ligan et al. 1987; Patel et al. 1996), inhibits dsRNA binding.
The K127A mutant R1 inhibited editing activity of R2Do n
the R/G 15 substrate (Fig. 6A, left panel, gray bars) at levels
similar to the wild-type R1, suggesting that this inhibition
does not result from a simple competition for RNA binding.
However, the inhibition of the R/G 27 reaction that occurs
at very high concentrations of the wild-type R1 was not
observed with the mutant R1 (Fig. 6A, right panel, gray
bars). Thus, this inhibition may occur by a simple compe-
tition of the dsRBM motifs (see Discussion).
Finally, we directly tested the ability of the isolated R1 and
the K127A mutant to bind RNA in a gel-shift assay. The
wild-type R1 bound the R/G 15 substrate only poorly, but
binding was reproducibly decreased with the K127A mu-
tant, as evident by an increase in the free, unbound RNA at
high concentrations (Fig. 6B). The wild-type R1 bound the
R/G 27 substrate, as well as a stem–loop that mimicked the
remaining portion of the R/G hairpin, not included in R/G
15, relatively tightly, with a Kd of <25 nM; the K127A mu-
tant bound these RNAs only weakly, with a Kd >500 nM
(Fig. 6B).
FIGURE 4. Purification of the R2D truncation. In the final step of
purification, the protein was chromatographed using Sephadex 200 gel
filtration resin. The UV trace from this column is shown with the
elution peaks of molecular weight standards (25, 43, and 67 kDa)
labeled. The Coomassie-stained SDS-PAGE analysis of fractions is
shown below the trace. The lanes under 22–25 mL show the trailing off
of the main hADAR2 peak; these bands are offset because they were
electrophoresed on a different gel.
FIGURE 5. Comparison of the deaminase activity of full-length
hADAR2 and the R2D truncation on RNA substrates of different
lengths. One hundred nanomolar hADAR2 or the R2D truncation
were incubated with 1 nM of an internally labeled ∼800-bp dsRNA
substrate or 5 nM of the R/G 27 or R/G 15 substrates (see Fig. 2C)
specifically labeled at the 5 phosphate of the edited adenosine. After
incubation for the times indicated, the reactions were stopped, and the
RNA was extracted with phenol and chloroform and digested with
Nuclease P1. The resulting 5 mononucleotides were separated by
TLC. (A) From left to right: TLC plates of the reaction of full-length
hADAR2 (top panels) or R2D truncation (lower panels) with each of
the three substrates. Positions of the origin (O), 5 AMP (pA), and 5
IMP (pI) are labeled. (B) The plot shows the fraction of IMP produced
as a function of time for the reaction of 100-nM enzyme and 5-nM
substrate. (Triangles) hADAR2 with R/G 27; (diamonds) R2D trun-
cation with R/G 27; (circles) R2D truncation with R/G 15; (squares)
hADAR2 with R/G 15. The data are the average of three independent
experiments and were fit to the equation Ft =F end(1 − e
−kt), where Ft
is the fraction of inosine at time t, Fend is the fraction of inosine at the
endpoint, and k is the fitted rate constant.
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The modular structure of ADARs
Limited proteolysis often provides information that is use-
ful for structure–function studies. With
this in mind, we performed limited pro-
teolysis on hADAR2. We found a strong
resistance of the known domains to pro-
teolysis, whereas the region between the
two dsRBMs was extremely susceptible
to cleavage. In this study, we addressed
two questions. First, do the proteolytic
fragments of hADAR2 edit RNA, and
second, what role do the dsRBMs and
the linker between them play in cataly-
sis? To answer these questions, we
cloned, expressed, and purified several
N-terminal deletion constructs and as-
sayed the ability of each construct to
deaminate RNA in vitro.
N-terminal deletions of hADAR2
From our proteolysis data, we generated
three N-terminal deletions of hADAR2.
The largest truncated protein (Trunca-
tion R1LR2D) contained a deletion that
removed the first 75 residues; this pro-
tein began two residues before the start
of dsRBM1. In vitro, R1LR2D retained
deaminase activity on a naturally occur-
ring substrate (Fig. 3B). A similar dele-
tion in the context of the D. melanogas-
ter ADAR binds dsRNA but is catalyti-
cally inactive (Gallo et al. 2003). Within
the deleted region of the fly protein is a
sequence necessary for editing and pro-
posed to be involved in RNA-dependent
dimerization. The apparent difference in
activities between our truncation and
the D. melanogaster truncation could be
due to the existence of an alternative
dimerization sequence in the human en-
zyme, or a different mechanism of acti-
vation.
The N terminus of truncation LR2D began 16 residues
after the first dsRBM. This protein contained most of the
linker between the two dsRBMs as well as the entire
dsRBM2 and catalytic domain. Interestingly, LR2D did not
edit the R/G site RNA when assayed in a crude extract but
did edit this RNA after further purification (data not
shown). Because further deletion of the linker to produce
the R2D truncation (see following) resulted in an active
protein, even in a crude extract, one explanation for this
result is that the linker of LR2D is associating with a protein
in the extract that inhibits activity.
The third truncated protein, R2D, contained a deletion
that removed the rest of the linker between the two
dsRBMs, leaving only dsRBM2 and the catalytic domain. To
TABLE 1. Single-turnover kinetic parameters
Reaction contents kobs,m i n
−1 Fend
ADAR + R/G 27 1.1 ± 0.07 0.93 ± .012
R2D+R / G2 7 0 . 3±0 . 0 3 0 . 8 9±0 . 0 3
R2D + R/G 15 0.016 ± 0.007 0.71 ± 0.05
ADAR + R/G 15 0.00073 ± 0.0006 0.04 ± 0.0019
FIGURE 6. The N terminus of hADAR2 inhibits R2D editing of R/G RNA when added in
trans.( A) Increasing concentrations of the isolated N terminus of hADAR2 (R1, residues
1–219) or the mutant R1-K127A was added to reactions containing 100 nM R2D and 20 nM
R/G 15 or R/G 27 labeled at the edited adenosine. The RNA was digested and editing was
analyzed by TLC as described in Materials and Methods. (Left panel) Editing of R/G 15
substrate; (right panel) editing of R/G 27 substrate; (black bars) wild-type R1; (gray bars)
R1-K127A. (B) Binding of the R1 constructs to R/G 15, R/G 27, or the R/G terminal hairpin
RNA. Increasing concentrations of the wild-type R1 (left panels) or the R1-K127A mutant (right
panels) were mixed with
32P end-labeled RNA, incubated at room temperature for 20 min, and
analyzed by native gel electrophoresis. The top panels show binding to R/G 15, middle panels
show binding to R/G 27, and lower panels show binding to the R/G terminal loop.
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both long dsRNA and R/G site RNA substrates with only a
slightly reduced rate compared with the full-length protein
(Fig. 5; Table 1).
An auto-inhibition model for hADAR2
We found that deletion of nearly half of hADAR2 (as in
R2D) caused only a three-fold reduction in activity, as as-
sayed with the R/G 27 RNA, a mimic of the naturally oc-
curring R/G editing site (Fig. 5; Table 1). However, when
the full-length hADAR2 and R2D were compared using the
shorter R/G 15 RNA, or a similar molecule, R/G 19 (data
not shown), the differences in activity were much more
dramatic. R2D efficiently deaminated these shorter sub-
strates, whereas the activity of the full-length enzyme was
almost undetectable. We also tested the specificity of R2D
by mapping inosines using a mutant form of ribonuclease
T1 (E64Q, Polson and Bass 1994) and found that the editing
pattern was identical to that produced by the full-length
hADAR2 (data not shown). As previously reported for
ADAR2 from rat (Kallman et al. 2003), we observed minor
editing by both R2D and hADAR2 at the adenosine imme-
diately 5 to the R/G site.
Figure 7 shows a model to explain the differences be-
tween the activities of full-length protein and R2D on short
substrates. The model assumes that in the absence of RNA,
the full-length hADAR2 is in an inactive conformation and
subject to auto-inhibition. Activation can only occur in the
presence of an RNA substrate that is long enough to ac-
commodate binding of both dsRBMs. On very short sub-
strates such as the R/G 15 RNA, there is no binding site for
dsRBM1 and no deamination of the R/G site. In contrast,
the R2D truncation is constitutively active and will deami-
nate RNA substrates regardless of their length.
The model implies that there are inhibitory sequences
in full-length hADAR2 that are absent in the R2D trunca-
tion. Indeed, we found that addition of the N terminus of
hADAR2 (R1) to a reaction containing the R2D protein, in
trans, mimicked the reaction of hADAR2; that is, activity
was only observed with longer RNA substrates. Reconstitu-
tion of the hADAR2 reaction in trans was observed even
with an R1 fragment mutated so as to eliminate dsRNA
binding (Fig. 6A). Thus, we do not think that inhibition
occurs simply because the two dsRBMs compete for RNA
binding. Rather, we speculate that inhibition in trans in-
volves a protein–protein interaction between components
of the N terminus that exist in R1 and the C terminus
(dsRBM2/catalytic domain) that prevents editing of short
duplexes. We tested whether the linker peptide (containing
amino acids 144–234) by itself could inhibit the R2D-R/G
15 reaction by adding it in trans. This peptide did not in-
hibit the reaction (data not shown) suggesting the inhibi-
tory region is N terminal to the linker, either within
dsRBM1 or the extreme N terminus.
The model of Figure 7 implies that the transition from an
inactive to active hADAR2 involves binding of dsRBM1.
Our gel-shift analyses of Figure 6B show that the R1 frag-
ment binds very poorly to R/G 15 but tightly to the R/G
terminal hairpin, which mimics the stem–loop region of the
natural R/G hairpin. The tighter binding to the R/G termi-
nal hairpin could be because this molecule is slightly longer
than R/G 15. However, we propose that
the terminal portion of the R/G hairpin
is a preferred site for dsRBM1. As shown
in our model, we speculate that binding
of dsRBM1 induces a conformational
change that effectively “unmasks”
dsRBM2 and the catalytic domain. We
also note that the R1 fragment binds to
R/G 27 nearly as well as the full-length
ADAR2 (see Fig. 6; Stephens et al. 2000).
This suggests that binding of the full-
length protein is predominantly a func-
tion of dsRBM1. Consistent with this
idea, the R2D truncation, which only has
dsRBM2, exhibits only minimal RNA
binding in a gel-shift analysis (data not
shown).
The data of Figure 6A show that R1
inhibits the reaction of R2D with R/G 27
(black bars, right panel) only when it is
present at very high concentrations. In
particular, inhibition by R1 is observed
when the R1 concentration exceeds the
concentration of R2D (100 nM). One
FIGURE 7. A model for RNA-mediated hADAR2 activation. The two horizontal panels illus-
trate the full-length hADAR2 and the R2D truncation, in the absence of RNA (left), in the
presence of a short RNA (center), or in the presence of a long RNA (right). The full-length
enzyme is inactive in the absence of RNA or in the presence of short RNA because the N
terminus inhibits association of dsRBM2 and the catalytic domain with the substrate. When a
longer RNA is present, dsRBM1 binds to a specific site, causing a conformational change that
allows dsRBM2 and the catalytic domain to bind as well, resulting in an active enzyme. The
R2D truncation does not contain the inhibitory region and is constitutively active on substrates
of any length.
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tion of R1 and R2D is very favorable; when R1 is present at
concentrations less than or equal to that of R2D, it is quan-
titatively associated with R2D and mediates binding to R/G
27 and relief of auto-inhibition. According to this hypoth-
esis, at high concentrations of R1 that exceed the amount of
R2D in the reaction, free R1, which lacks a catalytic domain,
would begin to compete with the catalytically active R1-R2D
molecule for RNA binding. Consistent with the idea that
this inhibition involves a competition for dsRNA binding, it
is not observed with the R1-K127A mutant, which cannot
bind dsRNA.
Several laboratories have reported that activation of cer-
tain ADARs involves RNA-dependent dimerization (Jai-
karan et al. 2002; Cho et al. 2003; Gallo et al. 2003). Our
studies have not addressed dimerization, but it is possible
that the activation we observe involves dimerization. The
dimerization domain in the D. melanogaster enzyme is in
the extreme N terminus, before dsRBM1, and deletion of
this sequence abolishes deaminase activity (Gallo et al.
2003). Our R1LR2D truncation of the human enzyme is
similar to this dADAR truncation, yet it retains a signifi-
cant amount of activity. Thus, if dimerization is involved in
hADAR2 activation, the dimerization motif in hADAR2
must be in a different region than that of the dADAR.
Activation by dimerization could also explain why hADAR2
does not deaminate R/G 15. If dimerization is required for
activity as proposed, R/G 15 could be too short to accom-
modate an ADAR2 dimer. As discussed earlier, our experi-
ments suggest the in trans association of R1 and R2D is very
favorable, and possibly this is because the association in-
volves dimerization.
Our model for activation of hADAR2 is reminiscent of
those proposed for another dsRNA binding protein, PKR. It
has been proposed that the cooperative binding of PKR’s
dsRBMs to dsRNA is responsible for activation, and per-
haps dimerization, and requires a substrate of at least 30 bp
(Manche et al. 1992; Carpick et al. 1997). In our model, we
propose that it is a sequence in the N-terminal fragment
(R1), which contains dsRBM1 but not dsRBM2, that pre-
vents hADAR2 from editing short RNAs. NMR data for
PKR, in the absence of RNA, suggest an interaction between
dsRBM2 and the kinase domain. From these data, it has
been suggested that dsRBM2 of PKR promotes auto-inhi-
bition by masking the kinase domain (Nanduri et al. 2000).
In the presence of dsRNA, dsRBM1 of PKR is proposed to
induce the cooperative binding of dsRBM2, which pro-
motes the active conformation, causing dimerization and
activation of the kinase. Although our data suggest dsRBM1
of hADAR2 is more important than dsRBM2 for activation,
as yet we cannot rule out an interaction between dsRBM2
and the catalytic domain. Although a construct similar to
R2D has not been analyzed for PKR, when both dsRBMs are
deleted from PKR, the resulting protein is constitutively active,
consistent with auto-inhibition (Wu and Kaufman 1997).
In summary, our data suggest hADAR2 is inactive in the
absence of dsRNA long enough to bind both dsRBMs. Our
results are consistent with, and help explain, the previous
observation that hADAR2 requires an extended duplex in
the HDV antigenomic RNA in order to edit the amber/W
site (Sato et al. 2001). One reason that hADAR2 might have
evolved such a regulatory mechanism is to ensure that
shorter dsRNA helixes, such as those found in endogenous
RNAs like rRNA, tRNA, and pre-miRNA, are not deami-
nated. Indeed, all of the edited sequences found in vivo are
in longer base-paired regions (Bass 2002; Maas et al. 2003).
MATERIALS AND METHODS
Limited proteolysis of hADAR2
hADAR2 was overexpressed and purified as described (Ley 2001).
Proteases (Sigma) were freshly prepared before use. Lyophilized
trypsin was resuspended in 50 mM acetic acid; lyophilized sub-
tilisin was resuspended in 50 mM Tris-HCl (pH 8.0) and 150 mM
NaCl. For a 10 µL reaction, 10 µg purified hADAR2 was mixed
with 0.01 µg of trypsin or 0.005 µg subtilisin in 50 mM NaHCO3.
Reactions proceeded at room temperature for varying times and
were quenched by adding 1 µL of 25 mM phenylmethylsulfonyl
fluoride and 10 µL SDS-PAGE loading buffer. Samples were boiled
(5 min), then electrophoresed in minigels containing a 4%–15%
polyacrylamide gradient. Peptide fragments were visualized with
Coomassie blue, or blotted onto a PVDF membrane, stained with
Coomassie blue, and submitted for N-terminal sequencing by Ed-
mann degradation according to published methods (Matsudaira
1987).
Construction, expression, and purification of hADAR2
deletion mutants
N-terminal deletions of hADAR2 were constructed by PCR am-
plification of the cDNA of hADAR2 in the expression vector
YEpTOP2PGAL1 (Ley 2001) using primers designed to produce
an ORF encoding a truncated hADAR2 of desired length. BsmBI
restriction sites, which when cut leave overhangs for BamHI at
the 5 end of the gene and XhoI at the 3 end of the gene,
were included in the forward and reverse primers and allowed for
ligation of the PCR product into the expression vector
YEpTOP2PGAL1 (Giaever et al. 1988; Ley 2001). The following
DNA oligonucleotides were used as upstream primers for ampli-
fying the truncated hADAR2 genes: RLRD-UP: CCCCCGTCTC
GGATCCGTAACCATGTCAGTCCTCCCCAAGAACGCCCTGA
TG; LRD-UP: CCCCCGTCTCGGATCCGTAACCATGTCAGTC
AACACGGACTTCACATCTGAC; RD-UP: CCCCCGTCTCGGA
TCCGTAACCATGTCAGGGAAGAATCCCGTGATGATCTTG.
The downstream primer for amplifying and adding six histidine
residues to these three constructs was as follows: A2His6-Down:
CCCCCGTCTCCTCGAGTCAATGGTGA TGGTGATGGTGGAC
TAGGGGCGTGA. For amplifying the RD truncation with a TEV-
cleavable 10×-histidine, the following upstream and downstream
primers were used. H10RD-UP: GGGCCCCGTCTCGGATCCG
TAACCATGTCACACCATCACCATCACCATCACCATCACCAT
GAGAACCTCTATTTCCAGGGAGCCAGCCTAGCCCAGCCTG
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CAGGGCGTGAGTGAGAACTGGTCCTG.
Truncated proteins were expressed in S. cerevisiae as described
for full-length ADAR2 (Ley 2001). To screen for expression, we
lysed 0.1 g of cells by vortexing with glass beads (30 min) at 4°C
in 20 mM Tris-HCl, 100 mM NaCl, 5% glycerol, 0.5 mM DTT,
and 0.01% Nonidet P-40. Lysate was clarified by centrifugation at
14,000 rpm in a microfuge, and expressed proteins were detected
by Western blotting using the Penta-His antibody (Qiagen). The
clarified lysate was analyzed for deaminase activity (see following),
and the remainder stored at −80°C. Truncation R2D was purified
as follows, with all manipulations carried out at 4°C: 25 g (wet wt)
of yeast cells were resuspended in 100 mL of Buffer A (20 mM
Tris-HCl at pH 8.0, 5% glycerol, 1 mM 2-mercaptoethanol) con-
taining 750 mM NaCl, 35 mM imidazole, and 0.01% Nonidet
P-40. Cells were lysed by three passes through a Gaulin homog-
enizer at 20,000 psi, and lysate was centrifuged at 100,000g f o r1h .
The supernatant was removed and mixed with 2.5 mL of Ni-NTA
agarose (Qiagen) equilibrated with lysis buffer, adsorbed for 10
min with gentle rocking, and poured into a column. The column
was washed in three steps with Buffer A containing 35 mM im-
idazole, and NaCl concentrations of 1 M, 500 mM, or 100 mM,
respectively. Protein was eluted with Buffer A containing 100 mM
NaCl and 400 mM imidazole and loaded ontoa5m LH i-Trap
Heparin column (Pharmacia) equilibrated with Buffer B (Buffer A
containing 100 mM NaCl). The column was washed with 50 mL of
Buffer B and developed with a 25 mL gradient of 100 mM–1 M
NaCl. Fractions were analyzed by electrophoresis on a 4%–15%
polyacrylamide gradient gel stained with Coomassie blue and
those containing truncated protein pooled and subjected to pro-
teolysis by the addition of 100 units of TEV protease (Invitrogen).
The reaction was dialyzed against Buffer B overnight, then bound
to 1 mL of Ni-NTA agarose for1hw i t hgentle rocking, and
poured into a column. The resin was washed with Buffer B con-
taining 15 mM imidazole, and the flowthrough and washes con-
taining the cleaved R2D truncation were pooled. The uncleaved
protein, TEV protease, and 10×-His tag were eluted by washing
with Buffer B containing 400 mM imidazole and discarded. The
protein was loaded on a Superdex 200 gel filtration column (Phar-
macia) developed in Buffer B; it eluted as one peak at a molecular
weight of 55 kDa, relative to the standards bovine serum albumin
(67 kDa), ovalbumin (43 kDa), and trypsin inhibitor (25kDa).
Fractions were analyzed by electrophoresis as described earlier,
and those containing R2D were pooled. The protein was dialyzed
into storage buffer containing 20 mM Tris-HCl (pH 8.0), 100 mM
NaCl, 20% glycerol, and 1 mM 2-mercaptoethanol; concentrated
using an Amicon Ultra-free 30 device; and quantified by the Brad-
ford method. The protein was stored in aliquots at −80°C and
typical yields were 2–3 mg of pure protein per liter of yeast culture.
The cDNA coding for the N terminus of hADAR2 spanning
residues 1–218 was amplified by PCR using the hADAR2 cDNA
template as described earlier. The product was ligated into the
expression vector pKM263 via the NcoI and BamHI restriction
sites (Melcher 2000). The translated protein is fused to the C
terminus of a histidine-tagged GST and is separated from GST by
a TEV protease recognition sequence. The K127A mutant R1 was
constructed using the QuickChange PCR mutagenesis kit (Bio-
crest) according to the manufacturer’s instructions. Protein was
expressed in Escherichia coli f o r3ha troom temperature after
induction with 0.2 mM IPTG. Cells were lysed by two passes
through a French pressure cell at 20,000 psi and the protein was
purified from the cleared lysate by nickel chromatography and
cleaved from GST by TEV protease as described earlier.
RNA preparation
R/G site hairpin and the R/G terminal hairpin were transcribed
from partially single-stranded DNA templates (Milligan et al.
1987; Lehmann and Bass 1999) and purified on a 12% denaturing
gel. CAT duplex RNA was labeled internally by transcribing with
-
32P ATP as previously described (Bass and Weintraub 1987).
The following DNA oligonucleotides were used for transcribing
the 71 nucleotide R/G hairpin: BB1BB: TAATACGACTCAC
TATAG and R/G hairpin: ACATCAGGGTAGGTGGGATAC
TATAACAACATTTAGCATATTGTTATACTATTCCACCCACCT
TAATGACCTATAGTGAGTCGTATTA. To specifically label
R/G 27 and R/G 15 RNA at the R/G editing site, we ligated two
RNA “half molecules” using a DNA splint and T4 DNA ligase as
previously described (Stephens et al. 2000). For the gel-shift assay,
the R/G terminal hairpin was transcribed using the BB1BB primer
and R/G-term: GGGATACTATAACAACATTTAGCATATTG
TTATACTATTCCTATAGTGAGTCGTATT. The RNA was de-
phosphorylated with calf intestinal phosphatase (New England
Biolabs) before gel purification. The 5 ends of the R/G terminal
hairpin and the top strand of R/G 15 were labeled with
32P using
polynucleotide kinase (New England Biolabs) and gamma
32P-
ATP (Amersham).
Deamination assays
Five or 15 µL of yeast extracts (prepared as described earlier) were
incubated with R/G hairpin RNA (final concentration 2.5 nM) for
1 h at 30°C in assay buffer (20 mM Tris-HCl at pH 7.5, 40 mM
KCl, 5% glycerol, 0.5 mM DTT, 0.01% Nonidet P-40, and 1 U/µL
RNasin (Promega). The RNA was extracted, and editing was
monitored by limited primer extension as described (Öhman et al.
2000). Purified hADAR2 (final concentration, 15 nM) and extract
prepared from yeast harboring an expression vector lacking the
ADAR gene were also reacted with R/G hairpin RNA as positive
and negative controls.
Editing of internally labeled RNAs (CAT duplex, R/G 27 and
R/G 15) by either purified hADAR2 or the R2D truncation was
monitored by TLC. One nanomolar CAT duplex RNA or 5 nM
R/G 27 or R/G 15 RNA was incubated with 100 nM enzyme in
assay buffer at 30°C for various times. At each time point, an
aliquot was removed and quenched by the addition of 0.5% SDS
and heating at 95°C (1 min). RNA was extracted and digested with
Nuclease P1 and the 5 nucleoside monophosphates resolved by
TLC as described (Lehmann and Bass 1999). For the single-turn-
over kinetic analysis, reactions were performed as described ear-
lier, except the time points were 0, 0.33, 0.67, 1, 2, 5, 10, 30, and
60 min. For the R1 inhibition experiments, 100 nM R2D was
mixed with R1 (at the final concentrations indicated in Fig. 6) and
incubated with 20 nM R/G RNA for 45 min at 30°C. The reactions
were processed as described earlier.
Gel mobility shift assay
Gel-shift assays were performed essentially as described (Öhman et
al. 2000), except for the following modifications. Either R2Do rR 1
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1570 RNA, Vol. 10, No. 10(at the concentrations indicated in Fig. 6) were incubated with
RNA in a buffer containing 20 mM Tris-HCl (pH 8.0), 40 mM
KCl, 15% glycerol, 0.5 mM DTT, 0.01% Nonidet P-40, and 1 U/µL
RNasin (Promega).
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